Contributors
Frederick W. Alt(Boston Children's Hospital), Hiroyuki Marusawa, Falk Hiepe(Leibniz Association), John F. Kearney(University of Alabama at Birmingham), Fabienne Mackay(QIMR Berghofer Medical Research Institute), Tasuku Honjo(Kyoto University), Jennifer L. Gommerman(University of Toronto), Tadamitsu Kishimoto(The University of Osaka), Anne Durandy(Hôpital Necker-Enfants Malades), Sidonia Fagarasan(Kyoto University), Carl S. Goodyear(University of Glasgow), Alain Fischer(Inserm), Max D. Cooper(Brighton and Sussex Medical School), Richard Chahwan(University of Exeter), Simon Fillatreau(Hôpital Necker-Enfants Malades), Sven Kracker(Délégation Paris 5), Andrea Cerutti(Institució Catalana de Recerca i Estudis Avançats), Masayuki Hirano(Emory University), Tomohiro Kurosaki(Osaka International University), Giuliana Magri(Barcelona Biomedical Research Park), Brantley R. Herrin(Emory Healthcare), Marc Feldmann(University of Oxford), Andreia C. Lino, James Hagman(National Jewish Health), Marie‐Paule Lefranc(Centre National de la Recherche Scientifique), Garnett Kelsoe(Duke University), Ellen Hilgenberg, Susanna M. Lewis, Alberto Martín(University of Toronto), Uta E. Höpken, Anja E. Hauser, Sabyasachi Das(Emory University), Alicia J. Little, Nasim A. Begum(Kyoto University), Hassan Jumaa(Max Planck Society), Michael C. Carroll(Boston Children's Hospital), Jianxu Li, Kyoko Hayakawa(Fox Chase Cancer Center), Betty Diamond(Feinstein Institute for Medical Research), Masaki Hikida, Maki Kobayashi, Barton F. Haynes(Duke University), Richard R. Hardy(University of Utah), Radbruch Andreas(German Rheumatism Research Centre), Tsutomu Chiba(Kyoto University), Ellen Hsu, Joseph Lucas, Van Duc Dang(German Rheumatism Research Centre), Ann J. Feeney(Scripps Research Institute), Riccardo Dalla‐Favera(Columbia University)
Cited by 0
Related Papers
Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation
|The Journal of Experimental Medicine|2000|5.2k
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|2.9k
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k